
Study: Blue Cross Backed Prescription Drug Initiative Drives Down Out-of-Pocket Costs by 64%
We all know prescription drug prices are too expensive. That's why BCBSM joined 22 other Blue plans to launch CivicaScript®, an initiative aimed at developing and manufacturing generic prescription drugs that are too expensive and too monopolized.